![[höher]](/style/images/multi_up.png)
Eine Ebene höherGruppiert nach:
Dokumententyp
| Veröffentlichungsdatum
Springe zu: Zeitschriftenartikel
Anzahl der Publikationen: 16
Zeitschriftenartikel
Hofstetter, Kerstin; Taugner, Julian 
ORCID: https://orcid.org/0000-0003-1473-1202; Käsmann, Lukas; Mansoorian, Sina; Flörsch, Benedikt; Eze, Chukwuka; Tufman, Amanda; Reinmuth, Niels; Duell, Thomas; Belka, Claus ORCID: https://orcid.org/0000-0002-1287-7825 und Manapov, Farkhad
(2023):
First-site-metastasis pattern in patients with inoperable stage III NSCLC treated with concurrent chemoradiotherapy with or without immune check-point inhibition: a retrospective analysis.
In: Strahlentherapie und Onkologie [Forthcoming]
[PDF, 465kB]
ORCID: https://orcid.org/0000-0003-1473-1202; Käsmann, Lukas; Mansoorian, Sina; Flörsch, Benedikt; Eze, Chukwuka; Tufman, Amanda; Reinmuth, Niels; Duell, Thomas; Belka, Claus ORCID: https://orcid.org/0000-0002-1287-7825 und Manapov, Farkhad
(2023):
First-site-metastasis pattern in patients with inoperable stage III NSCLC treated with concurrent chemoradiotherapy with or without immune check-point inhibition: a retrospective analysis.
In: Strahlentherapie und Onkologie [Forthcoming]
[PDF, 465kB]
Käsmann, Lukas; Eze, Chukwuka; Taugner, Julian; Nieto, Alexander; Hofstetter, Kerstin; Kröninger, Sophie; Guggenberger, Julian; Kenndoff, Saskia; Flörsch, Benedikt; Tufman, Amanda; Reinmuth, Niels; Duell, Thomas; Belka, Claus ORCID: https://orcid.org/0000-0002-1287-7825 und Manapov, Farkhad
(2023):
Concurrent/sequential versus sequential immune checkpoint inhibition in inoperable large stage III non-small cell lung cancer patients treated with chemoradiotherapy: a prospective observational study.
In: Journal of Cancer Research and Clinical Oncology, Bd. 149, Nr. 10: S. 7393-7403
[PDF, 1MB]
ORCID: https://orcid.org/0000-0002-1287-7825 und Manapov, Farkhad
(2023):
Concurrent/sequential versus sequential immune checkpoint inhibition in inoperable large stage III non-small cell lung cancer patients treated with chemoradiotherapy: a prospective observational study.
In: Journal of Cancer Research and Clinical Oncology, Bd. 149, Nr. 10: S. 7393-7403
[PDF, 1MB]
Taugner, Julian; Käsmann, Lukas; Karin, Monika; Eze, Chukwuka; Flörsch, Benedikt; Guggenberger, Julian; Li, Minglun; Tufman, Amanda; Reinmuth, Niels; Duell, Thomas; Belka, Claus und Manapov, Farkhad
(2022):
Planning target volume as a predictor of disease progression in inoperable stage III non-small cell lung cancer patients treated with chemoradiotherapy and concurrent and/or sequential immune checkpoint inhibition.
In: Investigational new drugs, Bd. 40: S. 163-171
[PDF, 1MB]
Flörsch, Benedikt; Taugner, Julian; Käsmann, Lukas; Kenndoff, Saskia; Guggenberger, Julian; Tufman, Amanda; Reinmuth, Niels; Duell, Thomas; Belka, Claus; Eze, Chukwuka und Manapov, Farkhad
(2022):
Treatment patterns and prognosis of patients with inoperable stage III NSCLC after completion of concurrent chemoradiotherapy +/- immune checkpoint inhibition: a decade-long single-center historical analysis.
In: Journal of Cancer Research and Clinical Oncology, Bd. 149, Nr. 7: S. 3267-3276
[PDF, 1MB]
Taugner, Julian; Käsmann, Lukas; Eze, Chukwuka; Rühle, Alexander; Tufman, Amanda; Reinmuth, Niels; Duell, Thomas; Belka, Claus ORCID: https://orcid.org/0000-0002-1287-7825 und Manapov, Farkhad
(2021):
Real-world prospective analysis of treatment patterns in durvalumab maintenance after chemoradiotherapy in unresectable, locally advanced NSCLC patients.
In: Investigational new drugs, Bd. 39: S. 1189-1196
[PDF, 586kB]
ORCID: https://orcid.org/0000-0002-1287-7825 und Manapov, Farkhad
(2021):
Real-world prospective analysis of treatment patterns in durvalumab maintenance after chemoradiotherapy in unresectable, locally advanced NSCLC patients.
In: Investigational new drugs, Bd. 39: S. 1189-1196
[PDF, 586kB]
Taugner, Julian; Kaesmann, Lukas; Eze, Chukwuka; Ruehle, Alexander; Tufman, Amanda; Reinmuth, Niels; Duell, Thomas; Belka, Claus und Manapov, Farkhad
(2021):
Real-world prospective analysis of treatment patterns in durvalumab maintenance after chemoradiotherapy in unresectable, locally advanced NSCLC patients.
In: Investigational New Drugs, Bd. 39, Nr. 4: S. 1189-1196
Taugner, Julian; Käsmann, Lukas; Eze, Chukwuka; Tufman, Amanda; Reinmuth, Niels; Duell, Thomas; Belka, Claus und Manapov, Farkhad
(2021):
Durvalumab after Chemoradiotherapy for PD-L1 Expressing Inoperable Stage III NSCLC Leads to Significant Improvement of Local-Regional Control and Overall Survival in the Real-World Setting.
In: Cancers, Bd. 13, Nr. 7, 1613
Taugner, Julian; Käsmann, Lukas; Karin, Monika; Eze, Chukwuka; Flörsch, Benedikt; Guggenberger, Julian; Li, Minglun; Tufman, Amanda; Reinmuth, Niels; Duell, Thomas; Belka, Claus und Manapov, Farkhad
(2021):
Planning target volume as a predictor of disease progression in inoperable stage III non-small cell lung cancer patients treated with chemoradiotherapy and concurrent and/or sequential immune checkpoint inhibition.
In: Investigational New Drugs, Bd. 40, Nr. 1: S. 163-171
Multhoff, Gabriele; Seier, Sophie; Stangl, Stefan; Sievert, Wolfgang; Shevtsov, Maxim; Werner, Caroline; Pockley, A. Graham; Blankenstein, Christiane; Hildebrandt, Martin; Offner, Robert; Ahrens, Norbert; Kokowski, Konrad; Hautmann, Matthias; Roedel, Claus; Fietkau, Rainer; Lubgan, Dorota; Huber, Rudolf; Hautmann, Hubert; Duell, Thomas; Molls, Michael; Specht, Hanno; Haller, Bernhard; Devecka, Michal; Sauter, Andreas und Combs, Stephanie E.
(2020):
Targeted Natural Killer Cell-Based Adoptive Immunotherapy for the Treatment of Patients with NSCLC after Radiochemotherapy: A Randomized Phase II Clinical Trial.
In: Clinical Cancer Research, Bd. 26, Nr. 20: S. 5368-5379
Biehl, Wiebke; Hattesohl, Akira; Jörres, Rudolf A. ORCID: https://orcid.org/0000-0002-9782-1117; Duell, Thomas; Althoehn, Ulrike; Koczulla, Andreas Rembert und Schmetzer, Helga
(2019):
VOC pattern recognition of lung cancer: a comparative evaluation of different dog- and eNose-based strategies using different sampling materials.
In: Acta Oncologica
ORCID: https://orcid.org/0000-0002-9782-1117; Duell, Thomas; Althoehn, Ulrike; Koczulla, Andreas Rembert und Schmetzer, Helga
(2019):
VOC pattern recognition of lung cancer: a comparative evaluation of different dog- and eNose-based strategies using different sampling materials.
In: Acta Oncologica
Klotz, Laura; Lindner, Michael; Eichhorn, Martin E.; Gruetzner, Uwe; Koch, Ina; Winter, Hauke; Kauke, Teresa; Duell, Thomas und Hatz, Rudolf A.
(2019):
Pleurectomy/decortication and hyperthermic intrathoracic chemoperfusion using cisplatin and doxorubicin for malignant pleural mesothelioma.
In: Journal of Thoracic Disease, Bd. 11, Nr. 5: S. 1963-1972
Tufman, Amanda; Duell, Thomas und Schneider, Christian
(2019):
Die Nachsorge des Lungenkarzinoms.
In: Zentralblatt für Chirurgie, Bd. 144, Nr. 1: S. 106-117
Tufman, Amanda; Kahnert, Kathrin; Duell, Thomas; Kauffmann-Guerrero, Diego; Milger, Katrin; Schneider, Christian; Stump, Julia; Syunyaeva, Zulfiya; Huber, Rudolf Maria und Reu, Simone
(2017):
Frequency and clinical relevance of EGFR mutations and EML4-ALK translocations in octogenarians with non-small cell lung cancer.
In: Oncotargets and therapy, Bd. 10: S. 5179-5186
[PDF, 535kB]
Specht, Hanno M.; Ahrens, Norbert; Blankenstein, Christiane; Duell, Thomas; Fietkau, Rainer; Gaipl, Udo S.; Günther, Christine; Gunther, Sophie; Habl, Gregor; Hautmann, Hubert; Hautmann, Matthias; Huber, Rudolf Maria; Molls, Michael; Offner, Robert; Rödel, Claus; Rödel, Franz; Schütz, Martin; Combs, Stephanie E. und Multhoff, Gabriele
(2015):
Heat shock protein 70 (Hsp70) peptide activated Natural Killer (NK) cells for the treatment of patients with non-small cell lung cancer (NSCLC) after radiochemotherapy (RCTx) - from preclinical studies to a clinical phase II trial.
In: Frontiers in Immunology, Bd. 6, UNSP 162
[PDF, 812kB]
Pawel, Joachim; Wagner, Horst; Duell, Thomas und Poellinger, Barbara
(2008):
Erlotinib in patients with previously irradiated, recurrent brain metastases from non-small cell lung cancer: Two case reports.
In: Onkologie, Nr. 3: S. 123-126
[PDF, 165kB]
Duell, Thomas; Poleck-Dehlin, Brigitte; Schmid, Christoph; Wunderlich, Bettina; Ledderose, Georg; Mittermueller, Johann; Kolb, Hans Jochem und Schmetzer, Helga Maria
(2006):
Clonal karyotype evolution involving ring chromosome 1 with myelodysplastic syndrome subtype RAEB-t progressing into acute leukemia.
In: Acta Haematologica, Nr. 2: S. 131-136
[PDF, 141kB]